FDA Adds New Warning to Deoxycholic Acid Label Over Off-Label Risks
FDA approves revised Kybella labeling flagging injection-site nodules, masses larger than 3 cm, and neuromuscular adverse events tied to off-label deoxycholic acid injection outside the submental fat…